Macrocycles in Drug Discovery
Jeremy Levin
Οκτ 2014 · Drug Discovery Series Βιβλίο 40 · Royal Society of Chemistry
ebook
528
Σελίδες
reportΟι αξιολογήσεις και οι κριτικές δεν επαληθεύονται Μάθετε περισσότερα
Σχετικά με το ebook
This book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
Σχετικά με τον συγγραφέα
Jeremy Levin is currently a Director of Medicinal Chemistry at Boehringer Ingelheim Pharmaceuticals, with a total of 25 years of experience in the pharmaceutical industry. He has worked in multiple therapeutic areas, including CNS, inflammation and immunology, and oncology. Dr Levin has authored or co-authored more than 70 papers in peer reviewed journals and served as an inventor on more than 60 issued U.S patents.
Αξιολογήστε αυτό το ebook
Πείτε μας τη γνώμη σας.
Πληροφορίες ανάγνωσης
Smartphone και tablet
Εγκαταστήστε την εφαρμογή Βιβλία Google Play για Android και iPad/iPhone. Συγχρονίζεται αυτόματα με τον λογαριασμό σας και σας επιτρέπει να διαβάζετε στο διαδίκτυο ή εκτός σύνδεσης, όπου κι αν βρίσκεστε.
Φορητοί και επιτραπέζιοι υπολογιστές
Μπορείτε να ακούσετε ηχητικά βιβλία τα οποία αγοράσατε στο Google Play, χρησιμοποιώντας το πρόγραμμα περιήγησης στον ιστό του υπολογιστή σας.
eReader και άλλες συσκευές
Για να διαβάσετε περιεχόμενο σε συσκευές e-ink, όπως είναι οι συσκευές Kobo eReader, θα χρειαστεί να κατεβάσετε ένα αρχείο και να το μεταφέρετε στη συσκευή σας. Ακολουθήστε τις αναλυτικές οδηγίες του Κέντρου βοήθειας για να μεταφέρετε αρχεία σε υποστηριζόμενα eReader.
